24 October 2024
London Stock Exchange Group plc: Q3 2024 Trading Update Strong Q3 performance, extending our track record of broad-based growth; further strategic progress David Schwimmer,…
Volume-led growth, positive in all Business Groups Third Quarter 2024 Nine Months 2024 (unaudited) USG Turnover vs 2023 USG Turnover vs 2023 Unilever 4.5% €15.2bn -% 4.3%…
· Single dose of vaccine elicited robust immune response with acceptable safety profile in adults aged 18-49 at increased risk for RSV-LRTD · Two doses of…
23 October 2024
23 October 2024 on track to deliver full year targets Q3 2024 YTD 2024 Net revenue £m LFL1 IFRS £m LFL1 IFRS Hygiene…
21 October 2024
21 October 2024 Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated…
16 October 2024
Rio Tinto releases third quarter production results 16 October 2024 Rio Tinto Chief Executive Jakob Stausholm said: “We continue to strengthen our operations, with…
Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents GSK plc (LSE/NYSE: GSK)…
14 October 2024
14 October 2024 LONDONMETRIC PROPERTY PLC Occupational activity adds £8.5 million of annual rental income LondonMetric Property Plc (“LondonMetric” or “Company”) announces an update…